Neurorehabilitation News

Health Canada has approved Daybue to treat Rett syndrome in patients aged 2 years and older, according to manufacturer Acadia Pharmaceuticals.

Early initiation and continuation of Kesimpta in those with relapsing MS was associated with lower rates of disability worsening up to 6 years compared with those who switched medication, according to a presentation at ECTRIMS 2024.

Topline results from the phase 3 SAPPHIRE clinical trial showed that an investigational muscle-targeted therapy improved motor function in patients with spinal muscular atrophy compared with placebo as early as week 8.

Boston Children’s Hospital has been named the best hospital in the country for pediatric neurology and neurosurgery, according to a press release from U.S. News & World Report.

The FDA has granted investigational device exemption to a clinical-stage health care firm for its proprietary neuroimmune modulation platform for individuals with relapsing-remitting MS, according to the manufacturer.

Interim results from the COMMAND study evaluating the safety and efficacy of the Synchron brain-computer interface device found no serious adverse device-related events at 12 months, the company announced.

ORLANDO, Fla. — An analysis of a large cohort of individuals enrolled in a continuous, multinational survey found no clear associations between brain and heart health and pet ownership, according to a poster.

ORLANDO, Fla. — A pilot study of direct spinal cord stimulation showed promise for improving motor function in a small cohort of individuals with gait freezing in Parkinson’s disease, according to a presenter.

ORLANDO, Fla. — Managing dystonic cerebral palsy in younger populations presents unique challenges, which may be addressed with direct cerebellar implantation of a deep brain stimulation device, according to a presenter.

ORLANDO, Fla. — An analysis of the gut microbiome among individuals who survived cancer revealed a significant association between the gut-brain axis, particularly in gut microbiota, metabolism and cognitive function, according to a poster.